Moderate dose capecitabine in older patients with metastatic breast cancer: A standard option for first line treatment?
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference41 articles.
1. Randomized, open label, phase II trial of oral capecitabine (Xeloda) vs a reference arm of CMF (cyclophosphamide, methotraxate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer;O’shauneghnessy;Ann Oncol,2001
2. A randomized trial of capecitabine given intermittently versus continuously versus classical CMF as first line chemotherapy for women with advanced breast cancer unsuited to more intensive treatment;Stockler;Breast Cancer Res Treat,2006
3. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer;Blum;J Clin Oncol,1999
4. Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients;Blum;Cancer,2001
5. Multicenter phase II study of oral capecitabine (Xeloda) in patients with metastatic breast cancer relapsing after treatment with taxane-containing therapy;Reichardt;Ann Oncol,2003
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A SENSITIVE AND ECONOMICAL DIFFERENT SPECTROSCOPIC METHODS DEVELOPMENT AND VALIDATION FOR THE QUANTIFICATION OF CAPECITABINE AND STRESS DEGRADATION STUDIES;International Journal of Applied Pharmaceutics;2023-05-07
2. The Impact of Age on Assessment and Treatment of Breast Cancer in Older People: You Are Only as Old as Your Oncologist Thinks You Are …;Clinical Oncology;2022-06
3. Dose Modification of Etoposide plus Platinum in Elderly Patients with Extensive-Disease Small-Cell Lung Cancer;Oncology;2022
4. Systemic Treatment of Metastatic Breast Cancer in Older Adults;Geriatric Oncology;2020
5. Capecitabine;Reactions Weekly;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3